US Patent Family Members and Approved Drugs for Canada Patent: 2096004
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: CA2096004
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,302,400 | 2040-03-30 | pancrelipase | Digestive Care, Inc. | PERTZYE |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
